US aesthetic mesotherapy company ABG Lasers is launching into the UK, bringing a range of aesthetic devices for a variety of aesthetic concerns.
According to the company, the company’s mesotherapy products target skin renewal, facial remodelling and hair loss through promoting skin repair with varying ingredients. The portfolio includes Meso-Wharton P199 for aged skin, Meso-Xanthin F199 for damaged skin, Mesosculpt C71 for facial contouring and Mesoeye C71 for periorbital correction.
President and CEO Dr Elina Tester commented, “Our mission statement is, first and foremost, to develop safe and optimal mesotherapy injections and anti-aging skincare technologies. ABG Lab is committed to improving skin health and beauty with products that protect the skin from damage and reduce the signs of aging, leading to a more youthful and radiant complexion. We develop solutions to help everyone experience the confidence and beauty of healthy, glowing skin now and for years to come.”
She continued, “The aesthetics market continues to be a pioneering space that leads the way in scientific progression and innovation. ABG Lab has a history of developing cutting-edge skincare technologies and intradermal injectables. This next phase is an exciting time for the company, paving the way for new products in 2023.”